Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
Complete the Trial Form Below:
You may be eligible for this study if you meet the following criteria:
Conditions: Diabetes Mellitus, Type 2
Age: Between 18 - 100 Years
Gender: Male or Female
The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to Placebo during long term treatment (52 weeks and longer) in combination with basal insulin in patients with type 2 diabetes mellitus with insufficient glycaemic control.